EGFR and cancer: Thus, the ligand-activated GPER triggers the Epidermal Growth Factor Receptor (EGFR)/extracellular signal–regulated kinases(ERK)/PKC signaling transduction pathway generating a feed forward loop that couples IL-1β induction by CAF to IL-1R1 expression by cancer cells [258].